EDSA Edesa Biotech, Inc.
$4.23▼ -9.23%
Healthcare
Other
After hours
$4.53▲ +7.09%
Sep 11, 7:38 PM ET
Volume 26.5K
Avg Volume (10D) 46.4K
Key Metrics & Fundamentals
Market Cap
$40.78M
P/E Ratio
–
Div Yield
–%
52W Range
0.72 - 20.32
% vs 50 MA
-23.34%
% vs 200 MA
-20.74%
RSI-14
32.8
MACD Histogram
+0.0200
Beta (1Y vs SPY)
-0.72
Free Cash Flow
-$3.08M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.39M
COGS
–
Operating Exp
$5.41M
Operating Income
-$5.41M
EBIT
-$5.41M
Pretax Income
-$5.41M
Net Income
-$5.41M
EPS (Diluted)
-0.60
Price & Volume History
Loading chart…
Recent News
3 Small Cap Biotech Stocks Trading At A Discount With Late Stage Clinical Catalysts
Simply Wall St. · Aug 28, 2026 4:44 AM
EDSA: Recruitment in Phase 2 Vitiligo Study Set to Get Underway
Zacks Small Cap Research · Aug 24, 2026 8:02 AM
Edesa Biotech Stock Sinks After Fresh Capital Raise
Benzinga · Aug 20, 2026 10:20 AM
Edesa Biotech Announces Pricing of $25.0 Million Public Offering
GlobeNewswire · Aug 20, 2026 2:20 AM
Edesa Biotech Launches Public Offering of Common Shares, Warrants
MT Newswires · Aug 19, 2026 9:04 PM
Edesa Biotech Announces Proposed Public Offering
GlobeNewswire · Aug 19, 2026 8:01 PM
Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results
GlobeNewswire · Aug 13, 2026 8:15 PM
EDSA: Positive Exploratory Data in Patients with AKI
Zacks Small Cap Research · Jul 2, 2026 12:02 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See EDSA's money flow as a full page
Social Sentiment
No Reddit posts found for EDSA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.